The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologics Outsourcing Market Research Report 2025
Synopsis
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
The global Biologics Outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biologics Outsourcing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biologics Outsourcing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biologics Outsourcing in Vaccine & Therapeutics Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biologics Outsourcing include Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private and Horizon Discovery Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Outsourcing.
Report Scope
The Biologics Outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Lonza
Abzena
Adimab
Segment by Type
Antibody
Recombinant
Protein
Vaccines
Others
Segment by Application
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
The global Biologics Outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biologics Outsourcing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biologics Outsourcing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biologics Outsourcing in Vaccine & Therapeutics Development is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biologics Outsourcing include Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private and Horizon Discovery Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Outsourcing.
Report Scope
The Biologics Outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Lonza
Abzena
Adimab
Segment by Type
Antibody
Recombinant
Protein
Vaccines
Others
Segment by Application
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Outsourcing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody
1.2.3 Recombinant
1.2.4 Protein
1.2.5 Vaccines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biologics Outsourcing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaccine & Therapeutics Development
1.3.3 Blood & Blood Related Products Testing
1.3.4 Cellular and Gene Therapy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Outsourcing Market Perspective (2019-2030)
2.2 Biologics Outsourcing Growth Trends by Region
2.2.1 Global Biologics Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Outsourcing Historic Market Size by Region (2019-2024)
2.2.3 Biologics Outsourcing Forecasted Market Size by Region (2025-2030)
2.3 Biologics Outsourcing Market Dynamics
2.3.1 Biologics Outsourcing Industry Trends
2.3.2 Biologics Outsourcing Market Drivers
2.3.3 Biologics Outsourcing Market Challenges
2.3.4 Biologics Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Outsourcing Players by Revenue
3.1.1 Global Top Biologics Outsourcing Players by Revenue (2019-2024)
3.1.2 Global Biologics Outsourcing Revenue Market Share by Players (2019-2024)
3.2 Global Biologics Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Outsourcing Revenue
3.4 Global Biologics Outsourcing Market Concentration Ratio
3.4.1 Global Biologics Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Outsourcing Revenue in 2023
3.5 Biologics Outsourcing Key Players Head office and Area Served
3.6 Key Players Biologics Outsourcing Product Solution and Service
3.7 Date of Enter into Biologics Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Outsourcing Breakdown Data by Type
4.1 Global Biologics Outsourcing Historic Market Size by Type (2019-2024)
4.2 Global Biologics Outsourcing Forecasted Market Size by Type (2025-2030)
5 Biologics Outsourcing Breakdown Data by Application
5.1 Global Biologics Outsourcing Historic Market Size by Application (2019-2024)
5.2 Global Biologics Outsourcing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics Outsourcing Market Size (2019-2030)
6.2 North America Biologics Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics Outsourcing Market Size by Country (2019-2024)
6.4 North America Biologics Outsourcing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Outsourcing Market Size (2019-2030)
7.2 Europe Biologics Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics Outsourcing Market Size by Country (2019-2024)
7.4 Europe Biologics Outsourcing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Outsourcing Market Size (2019-2030)
8.2 Asia-Pacific Biologics Outsourcing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics Outsourcing Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologics Outsourcing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Outsourcing Market Size (2019-2030)
9.2 Latin America Biologics Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics Outsourcing Market Size by Country (2019-2024)
9.4 Latin America Biologics Outsourcing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Outsourcing Market Size (2019-2030)
10.2 Middle East & Africa Biologics Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics Outsourcing Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologics Outsourcing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Biologics Outsourcing Introduction
11.1.4 Boehringer Ingelheim Revenue in Biologics Outsourcing Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Biologics Outsourcing Introduction
11.2.4 Catalent Revenue in Biologics Outsourcing Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 GenScript
11.3.1 GenScript Company Detail
11.3.2 GenScript Business Overview
11.3.3 GenScript Biologics Outsourcing Introduction
11.3.4 GenScript Revenue in Biologics Outsourcing Business (2019-2024)
11.3.5 GenScript Recent Development
11.4 Innovent Biologics
11.4.1 Innovent Biologics Company Detail
11.4.2 Innovent Biologics Business Overview
11.4.3 Innovent Biologics Biologics Outsourcing Introduction
11.4.4 Innovent Biologics Revenue in Biologics Outsourcing Business (2019-2024)
11.4.5 Innovent Biologics Recent Development
11.5 Syngene
11.5.1 Syngene Company Detail
11.5.2 Syngene Business Overview
11.5.3 Syngene Biologics Outsourcing Introduction
11.5.4 Syngene Revenue in Biologics Outsourcing Business (2019-2024)
11.5.5 Syngene Recent Development
11.6 Shanghai Medicilon
11.6.1 Shanghai Medicilon Company Detail
11.6.2 Shanghai Medicilon Business Overview
11.6.3 Shanghai Medicilon Biologics Outsourcing Introduction
11.6.4 Shanghai Medicilon Revenue in Biologics Outsourcing Business (2019-2024)
11.6.5 Shanghai Medicilon Recent Development
11.7 GL Biochem Corporation
11.7.1 GL Biochem Corporation Company Detail
11.7.2 GL Biochem Corporation Business Overview
11.7.3 GL Biochem Corporation Biologics Outsourcing Introduction
11.7.4 GL Biochem Corporation Revenue in Biologics Outsourcing Business (2019-2024)
11.7.5 GL Biochem Corporation Recent Development
11.8 GVK Biosciences Private
11.8.1 GVK Biosciences Private Company Detail
11.8.2 GVK Biosciences Private Business Overview
11.8.3 GVK Biosciences Private Biologics Outsourcing Introduction
11.8.4 GVK Biosciences Private Revenue in Biologics Outsourcing Business (2019-2024)
11.8.5 GVK Biosciences Private Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group Biologics Outsourcing Introduction
11.9.4 Horizon Discovery Group Revenue in Biologics Outsourcing Business (2019-2024)
11.9.5 Horizon Discovery Group Recent Development
11.10 Selexis
11.10.1 Selexis Company Detail
11.10.2 Selexis Business Overview
11.10.3 Selexis Biologics Outsourcing Introduction
11.10.4 Selexis Revenue in Biologics Outsourcing Business (2019-2024)
11.10.5 Selexis Recent Development
11.11 Lonza
11.11.1 Lonza Company Detail
11.11.2 Lonza Business Overview
11.11.3 Lonza Biologics Outsourcing Introduction
11.11.4 Lonza Revenue in Biologics Outsourcing Business (2019-2024)
11.11.5 Lonza Recent Development
11.12 Abzena
11.12.1 Abzena Company Detail
11.12.2 Abzena Business Overview
11.12.3 Abzena Biologics Outsourcing Introduction
11.12.4 Abzena Revenue in Biologics Outsourcing Business (2019-2024)
11.12.5 Abzena Recent Development
11.13 Adimab
11.13.1 Adimab Company Detail
11.13.2 Adimab Business Overview
11.13.3 Adimab Biologics Outsourcing Introduction
11.13.4 Adimab Revenue in Biologics Outsourcing Business (2019-2024)
11.13.5 Adimab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biologics Outsourcing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibody
Table 3. Key Players of Recombinant
Table 4. Key Players of Protein
Table 5. Key Players of Vaccines
Table 6. Key Players of Others
Table 7. Global Biologics Outsourcing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Biologics Outsourcing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Biologics Outsourcing Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Biologics Outsourcing Market Share by Region (2019-2024)
Table 11. Global Biologics Outsourcing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Biologics Outsourcing Market Share by Region (2025-2030)
Table 13. Biologics Outsourcing Market Trends
Table 14. Biologics Outsourcing Market Drivers
Table 15. Biologics Outsourcing Market Challenges
Table 16. Biologics Outsourcing Market Restraints
Table 17. Global Biologics Outsourcing Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Biologics Outsourcing Market Share by Players (2019-2024)
Table 19. Global Top Biologics Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Outsourcing as of 2023)
Table 20. Ranking of Global Top Biologics Outsourcing Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Biologics Outsourcing Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biologics Outsourcing Product Solution and Service
Table 24. Date of Enter into Biologics Outsourcing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biologics Outsourcing Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Biologics Outsourcing Revenue Market Share by Type (2019-2024)
Table 28. Global Biologics Outsourcing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Biologics Outsourcing Revenue Market Share by Type (2025-2030)
Table 30. Global Biologics Outsourcing Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Biologics Outsourcing Revenue Market Share by Application (2019-2024)
Table 32. Global Biologics Outsourcing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Biologics Outsourcing Revenue Market Share by Application (2025-2030)
Table 34. North America Biologics Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Biologics Outsourcing Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Biologics Outsourcing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Biologics Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Biologics Outsourcing Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Biologics Outsourcing Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Biologics Outsourcing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Biologics Outsourcing Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Biologics Outsourcing Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Biologics Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Biologics Outsourcing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Biologics Outsourcing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Biologics Outsourcing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Biologics Outsourcing Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Biologics Outsourcing Market Size by Country (2025-2030) & (US$ Million)
Table 49. Boehringer Ingelheim Company Detail
Table 50. Boehringer Ingelheim Business Overview
Table 51. Boehringer Ingelheim Biologics Outsourcing Product
Table 52. Boehringer Ingelheim Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 53. Boehringer Ingelheim Recent Development
Table 54. Catalent Company Detail
Table 55. Catalent Business Overview
Table 56. Catalent Biologics Outsourcing Product
Table 57. Catalent Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 58. Catalent Recent Development
Table 59. GenScript Company Detail
Table 60. GenScript Business Overview
Table 61. GenScript Biologics Outsourcing Product
Table 62. GenScript Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 63. GenScript Recent Development
Table 64. Innovent Biologics Company Detail
Table 65. Innovent Biologics Business Overview
Table 66. Innovent Biologics Biologics Outsourcing Product
Table 67. Innovent Biologics Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 68. Innovent Biologics Recent Development
Table 69. Syngene Company Detail
Table 70. Syngene Business Overview
Table 71. Syngene Biologics Outsourcing Product
Table 72. Syngene Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 73. Syngene Recent Development
Table 74. Shanghai Medicilon Company Detail
Table 75. Shanghai Medicilon Business Overview
Table 76. Shanghai Medicilon Biologics Outsourcing Product
Table 77. Shanghai Medicilon Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 78. Shanghai Medicilon Recent Development
Table 79. GL Biochem Corporation Company Detail
Table 80. GL Biochem Corporation Business Overview
Table 81. GL Biochem Corporation Biologics Outsourcing Product
Table 82. GL Biochem Corporation Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 83. GL Biochem Corporation Recent Development
Table 84. GVK Biosciences Private Company Detail
Table 85. GVK Biosciences Private Business Overview
Table 86. GVK Biosciences Private Biologics Outsourcing Product
Table 87. GVK Biosciences Private Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 88. GVK Biosciences Private Recent Development
Table 89. Horizon Discovery Group Company Detail
Table 90. Horizon Discovery Group Business Overview
Table 91. Horizon Discovery Group Biologics Outsourcing Product
Table 92. Horizon Discovery Group Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 93. Horizon Discovery Group Recent Development
Table 94. Selexis Company Detail
Table 95. Selexis Business Overview
Table 96. Selexis Biologics Outsourcing Product
Table 97. Selexis Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 98. Selexis Recent Development
Table 99. Lonza Company Detail
Table 100. Lonza Business Overview
Table 101. Lonza Biologics Outsourcing Product
Table 102. Lonza Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 103. Lonza Recent Development
Table 104. Abzena Company Detail
Table 105. Abzena Business Overview
Table 106. Abzena Biologics Outsourcing Product
Table 107. Abzena Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 108. Abzena Recent Development
Table 109. Adimab Company Detail
Table 110. Adimab Business Overview
Table 111. Adimab Biologics Outsourcing Product
Table 112. Adimab Revenue in Biologics Outsourcing Business (2019-2024) & (US$ Million)
Table 113. Adimab Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics Outsourcing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biologics Outsourcing Market Share by Type: 2023 VS 2030
Figure 3. Antibody Features
Figure 4. Recombinant Features
Figure 5. Protein Features
Figure 6. Vaccines Features
Figure 7. Others Features
Figure 8. Global Biologics Outsourcing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Biologics Outsourcing Market Share by Application: 2023 VS 2030
Figure 10. Vaccine & Therapeutics Development Case Studies
Figure 11. Blood & Blood Related Products Testing Case Studies
Figure 12. Cellular and Gene Therapy Case Studies
Figure 13. Other Case Studies
Figure 14. Biologics Outsourcing Report Years Considered
Figure 15. Global Biologics Outsourcing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Biologics Outsourcing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Biologics Outsourcing Market Share by Region: 2023 VS 2030
Figure 18. Global Biologics Outsourcing Market Share by Players in 2023
Figure 19. Global Top Biologics Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Outsourcing as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Biologics Outsourcing Revenue in 2023
Figure 21. North America Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Biologics Outsourcing Market Share by Country (2019-2030)
Figure 23. United States Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Biologics Outsourcing Market Share by Country (2019-2030)
Figure 27. Germany Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Biologics Outsourcing Market Share by Region (2019-2030)
Figure 35. China Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Biologics Outsourcing Market Share by Country (2019-2030)
Figure 43. Mexico Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Biologics Outsourcing Market Share by Country (2019-2030)
Figure 47. Turkey Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Biologics Outsourcing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 50. Catalent Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 51. GenScript Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 52. Innovent Biologics Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 53. Syngene Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 54. Shanghai Medicilon Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 55. GL Biochem Corporation Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 56. GVK Biosciences Private Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 57. Horizon Discovery Group Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 58. Selexis Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 59. Lonza Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 60. Abzena Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 61. Adimab Revenue Growth Rate in Biologics Outsourcing Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
